Will immunogenicity limit the use, efficacy, and future development of therapeutic monoclonal antibodies?

K. Kuus-Reichel, L. S. Grauer, L. M. Karavodin, C. Knott, M. Krusemeier, N. E. Kay

Research output: Contribution to journal › Review article › peer-review

155 Scopus citations

Fingerprint

Dive into the research topics of 'Will immunogenicity limit the use, efficacy, and future development of therapeutic monoclonal antibodies?'. Together they form a unique fingerprint.